SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0000950123-00-001773
Filing Date
2000-02-29
Accepted
2000-02-29 00:00:00
Documents
14

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION F-1 294839
2 COMMON STOCK PURCHASE AGREEMENT EX-2.0 76754
3 REGISTRATION RIGHTS AGREEMENT EX-2.1 35992
4 ESCROW AGREEMENT EX-2.2 12680
5 STOCK PURCHASE WARRANT EX-2.3 29833
6 ARTICLES OF INCORPORATION EX-3.0 38175
7 BYLAWS OF NYMOX PHARMACEUTICAL CORPORATION EX-3.1 45789
8 OPINION OF FOLEY & LARDNER EX-5.1 6162
9 OPINION OF STIKMAN, ELLIOTT EX-5.2 11177
10 EMPLOYMENT AGREEMENT EX-10.1 34732
11 CONSENT OF KPMG EX-23.1 625
12 POWER OF ATTORNEY EX-24.0 2368
13 FINANCIAL DATA SCHEDULE EX-27.0 2332
14 PRESS RELEASE EX-99.0 2658
  Complete submission text file 0000950123-00-001773.txt   596867
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-3222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-31310 | Film No.: 557218
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1